These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 15913921

  • 1. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
    Zimmermann P, Wittchen HU, Waszak F, Nocon A, Höfler M, Lieb R.
    Drug Alcohol Depend; 2005 Sep 01; 79(3):331-41. PubMed ID: 15913921
    [Abstract] [Full Text] [Related]

  • 2. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul 01; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 3. Club drug use in Germany.
    Soellner R.
    Subst Use Misuse; 2005 Jul 01; 40(9-10):1279-93. PubMed ID: 16048817
    [Abstract] [Full Text] [Related]

  • 4. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.
    Encephale; 2009 Jun 01; 35(3):226-33. PubMed ID: 19540408
    [Abstract] [Full Text] [Related]

  • 5. Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance?
    Alati R, Kinner SA, Hayatbakhsh MR, Mamun AA, Najman JM, Williams GM.
    Drug Alcohol Depend; 2008 Jan 01; 92(1-3):108-15. PubMed ID: 17850992
    [Abstract] [Full Text] [Related]

  • 6. Dependence symptoms in young cannabis users? A prospective epidemiological study.
    Nocon A, Wittchen HU, Pfister H, Zimmermann P, Lieb R.
    J Psychiatr Res; 2006 Aug 01; 40(5):394-403. PubMed ID: 16169014
    [Abstract] [Full Text] [Related]

  • 7. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C, Fisk JE.
    J Psychopharmacol; 2007 Sep 01; 21(7):709-17. PubMed ID: 17606476
    [Abstract] [Full Text] [Related]

  • 8. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.
    de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W.
    J Psychopharmacol; 2006 Mar 01; 20(2):226-35. PubMed ID: 16510480
    [Abstract] [Full Text] [Related]

  • 9. Major depression: the relative contribution of gender, MDMA, and cannabis use.
    Durdle H, Lundahl LH, Johanson CE, Tancer M.
    Depress Anxiety; 2008 Mar 01; 25(3):241-7. PubMed ID: 17345601
    [Abstract] [Full Text] [Related]

  • 10. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM, Parrott AC, Schifano F, Turner JJ.
    Hum Psychopharmacol; 2005 Jun 01; 20(4):249-61. PubMed ID: 15816011
    [Abstract] [Full Text] [Related]

  • 11. Is the use of ecstasy and hallucinogens increasing? Results from a community study.
    Schuster P, Lieb R, Lamertz C, Wittchen HU.
    Eur Addict Res; 1998 Mar 01; 4(1-2):75-82. PubMed ID: 9740820
    [Abstract] [Full Text] [Related]

  • 12. Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study.
    Hopper JW, Su Z, Looby AR, Ryan ET, Penetar DM, Palmer CM, Lukas SE.
    Drug Alcohol Depend; 2006 Dec 01; 85(3):221-35. PubMed ID: 16730923
    [Abstract] [Full Text] [Related]

  • 13. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR, Kokkalis J.
    Hum Psychopharmacol; 2007 Aug 01; 22(6):381-8. PubMed ID: 17621368
    [Abstract] [Full Text] [Related]

  • 14. A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs.
    Wittchen HU, Behrendt S, Höfler M, Perkonigg A, Rehm J, Lieb R, Beesdo K.
    Drug Alcohol Depend; 2009 Jun 01; 102(1-3):151-7. PubMed ID: 19362792
    [Abstract] [Full Text] [Related]

  • 15. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A.
    Hum Psychopharmacol; 2003 Mar 01; 18(2):89-90. PubMed ID: 12590401
    [No Abstract] [Full Text] [Related]

  • 16. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J, Fischermann T, Heekeren K, Thron A, Gouzoulis-Mayfrank E.
    Biol Psychiatry; 2004 Sep 01; 56(5):349-55. PubMed ID: 15336517
    [Abstract] [Full Text] [Related]

  • 17. Correlates of Ecstasy use in middle age and beyond.
    Williams P.
    Drug Alcohol Rev; 2005 Jan 01; 24(1):33-8. PubMed ID: 16191719
    [Abstract] [Full Text] [Related]

  • 18. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Schütz CG.
    J Psychopharmacol; 2009 Jul 01; 23(5):495-509. PubMed ID: 18635709
    [Abstract] [Full Text] [Related]

  • 19. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J, Till B, Fischermann T, Rezk M, Gouzoulis-Mayfrank E.
    J Psychopharmacol; 2006 Mar 01; 20(2):236-44. PubMed ID: 16510481
    [Abstract] [Full Text] [Related]

  • 20. The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory.
    Murphy PN, Erwin PG, Maciver L, Fisk JE, Larkin D, Wareing M, Montgomery C, Hilton J, Tames FJ, Bradley B, Yanulevitch K, Ralley R.
    Hum Psychopharmacol; 2011 Oct 01; 26(7):460-9. PubMed ID: 21898599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.